Dov A. Goldstein M.D., Chief Financial Officer at BioAge Labs, Inc. (BIOA), sold 54,000 shares at $18.43 ($1.1M) on 2026-01-13, disclosed to the SEC on 2026-01-15.
Open-market sale of $1.1M BIOA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.43 | 8,974 | $165K | 15.5% |
| 2 | $18.43 | 8,974 | $165K | 15.5% |
| 3 | $19.45 | 4,440 | $86K | 8.1% |
| 4 | $19.45 | 4,440 | $86K | 8.1% |
| 5 | $20.54 | 11,663 | $240K | 22.5% |
| 6 | $20.54 | 11,663 |
| $240K |
| 22.5% |
| 7 | $21.08 | 1,923 | $41K | 3.8% |
| 8 | $21.08 | 1,923 | $41K | 3.8% |
| Total | $19.70 avg | 54,000 | $1.1M | 100% |
| Filing → |
| NBSE | BUY | 2020-05-04 | $60K | — | Filing → |
| ESPR | SELL | 2017-03-23 | $66.7M | — | Filing → |
| CEMP | SELL | 2017-03-09 | $533K | — | Filing → |